Showing results (41-50 of 45) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Neurogastroenterology and Motility|March 25, 2017
The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux diseaseM-L Rouzade-Dominguez, N Pezous, O J David, et al.Alimentary Pharmacology & Therapeutics|June 16, 2011
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux diseaseE Savarino, L Gemignani, D Pohl, et al.Neurogastroenterology and Motility|December 15, 2015
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERDI Martinucci, E V Savarino, J E Pandolfino, et al.Neurogastroenterology and Motility|April 4, 2017
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus groupS Roman, C P Gyawali, E Savarino, et al.Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 5, 2014
Inter-observer agreement for diagnostic classification of esophageal motility disorders defined in high-resolution manometryM R Fox, J E Pandolfino, R Sweis, et al.Pageof 5